ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P ASX 200
7,073.20
(
0.0%
)
S&P ASX All Technology
2,475.10
(
0.0%
)
Brent Oil
79.125
(
0.0%
)
US Dollar vs AUD
1.49993
(
0.0%
)
Bitcoin
39,583.36
(
0.26%
)
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aldeyra Therapeutics Inc (ALDX)

  7. Aldeyra Therapeutics Inc (ALDX) News

ALDX Aldeyra Therapeutics Inc

2.86
0.079 (2.84%)
02 Dec 2023 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Aldeyra Therapeutics Inc ALDX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.079 2.84% 2.86 12:00:00
Open Price Low Price High Price Close Price Previous Close
2.82 2.69 2.90 2.86 2.781
more quote information »

Recent News

Date Time Source Heading
28/11/202323:16EDGAR2Form 8-K - Current report
28/11/202308:07BWAldeyra Therapeutics Receives Complete Response Letter from..
04/11/202307:43EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/11/202307:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202322:09EDGAR2Form 8-K - Current report
01/11/202322:05BWAldeyra Therapeutics Enters into Exclusive Option Agreement..
16/10/202323:00EDGAR2Form 8-K - Current report
27/9/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
26/9/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
19/9/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
12/9/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
12/9/202307:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
25/8/202306:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
16/8/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
11/8/202319:45PRNUSALDX SHAREHOLDER ALERT: Jakubowitz Law Reminds Aldeyra..
09/8/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
04/8/202319:45PRNUSALDX SHAREHOLDER ALERT: Jakubowitz Law Reminds Aldeyra..
04/8/202306:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/7/202321:00BWAldeyra Therapeutics to Participate in SVB Securities..
06/7/202307:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/7/202307:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/7/202307:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/7/202306:07EDGAR2Form 8-K - Current report
30/6/202306:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/6/202321:01EDGAR2Form 8-K - Current report
29/6/202321:00BWAldeyra Therapeutics Announces Improvement from Baseline in..
29/6/202306:01BWAldeyra Therapeutics Schedules Conference Call and Webcast..
27/6/202321:00BWAldeyra Therapeutics Announces Statistically Significant..
27/6/202306:01BWAldeyra Therapeutics Schedules Conference Call and Webcast..
23/6/202321:00BWAldeyra Therapeutics to Join the Russell 2000® and Russell..
21/6/202323:34BWAldeyra Therapeutics Provides Regulatory Update on ADX-2191
15/6/202321:00BWAldeyra Therapeutics Announces Achievement of Statistical..
15/6/202306:01BWAldeyra Therapeutics Schedules Conference Call and Webcast..
02/6/202321:00BWAldeyra Therapeutics to Participate in Fireside Chat at the..
04/5/202321:00BWAldeyra Therapeutics Reports First-Quarter 2023 Financial..
13/4/202321:00BWAldeyra Therapeutics Completes Enrollment in Phase 3..
06/4/202321:00BWAldeyra Therapeutics Enrolls First Patient in Phase 2..
30/3/202322:00BWAldeyra Therapeutics Announces Completion of Enrollment in..
16/3/202322:00BWAldeyra Therapeutics Announces Completion of Enrollment in..
09/3/202323:00BWAldeyra Therapeutics Reports Full-Year 2022 Financial..
02/3/202323:00BWFDA Accepts for Priority Review ADX-2191 New Drug..
01/3/202323:00BWAldeyra Therapeutics Schedules Webcast and Conference Call..
28/2/202323:00BWAldeyra Therapeutics Announces Positive Top-Line Results..
23/2/202323:00BWAldeyra Therapeutics Announces Next-Generation..
16/2/202323:00BWAldeyra Therapeutics Advances Investigational Oral RASP..
09/2/202323:00BWAldeyra Therapeutics to Participate in Fireside Chat at the..
07/2/202323:00BWAldeyra Therapeutics Announces FDA Acceptance of New Drug..
21/12/202223:00BWAldeyra Therapeutics Submits New Drug Application to the..

Your Recent History

NASDAQ
ALDX
Aldeyra Therapeutics
Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com